# Eli Lilly (LLY) — News

LLY · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/lly/news

## Recent headlines

- **Important** — [Eli Lilly interested in Ibogaire research: Neuroscience chief](https://www.ainvest.com/news/eli-lilly-interested-ibogaire-research-neuroscience-chief-2610) — AInvest Wire, Oct 15, 2026
- [S&P 500 healthcare index hits record high; last up 2.8%](https://www.ainvest.com/news/500-healthcare-index-hits-record-high-2-8-2610) — AInvest Wire, Oct 15, 2026
  The S&P 500 Health Care Sector Index reached a record high on October 15, 2026, rising 2.8% amid strong performance from key pharmaceutical and biotechnology firms. The index has benefited from recent earnings reports and strategic developments within the sector. Eli Lilly and Company (LLY), a…
- [Bio-pharmaceutical stocks rose in regular trading, with VOGX up 6.61%, LLY gaining 5.01% and EQ rising 5.00%.](https://www.ainvest.com/news/bio-pharmaceutical-stocks-rose-regular-trading-vogx-6-61-lly-gaining-5-01-eq-rising-5-00-2610-71) — AInvest Wire, Oct 15, 2026
  On October 15, 2026, bio-pharmaceutical stocks showed notable gains during regular trading hours. Vogenx Inc. (NASDAQ: VOGX) led the sector with a 6.61% increase, reflecting investor confidence in recent developments . Eli Lilly and Company (LLY) also performed well, with shares rising by 5.01% .…
- [Alzheimer stocks rose in regular trading, with Eli Lilly up 4.3%, Anavex Life Sciences gaining 3.7% and Biogen rising 3.3%.](https://www.ainvest.com/news/alzheimer-stocks-rose-regular-trading-eli-lilly-4-3-anavex-life-sciences-gaining-3-7-biogen-rising-3-3-2610-18) — AInvest Wire, Oct 15, 2026
  Alzheimer’s-related stocks saw gains in regular trading on October 15, 2026, with Eli Lilly rising 4.3%, Anavex Life Sciences up 3.7%, and Biogen increasing by 3.3%. The movement reflects investor interest in the sector, particularly in companies advancing therapies for neurodegenerative diseases.…
- [Eli Lilly - 23.4% of omvoh-treated UC patients with prior biologic failure achieve comprehensive disease control](https://www.ainvest.com/news/eli-lilly-23-4-omvoh-treated-uc-patients-prior-biologic-failure-achieve-comprehensive-disease-control-2610) — AInvest Wire, Oct 15, 2026

## Similar Stocks

- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock
- [AMGN](https://www.lighthorse.io/tickers/amgn) — Amgen Inc. - Common Stock
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock
- [VKTX](https://www.lighthorse.io/tickers/vktx) — Viking Therapeutics, Inc. - Common Stock
- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [BIIB](https://www.lighthorse.io/tickers/biib) — Biogen Inc. - Common Stock
- [NVDA](https://www.lighthorse.io/tickers/nvda) — NVIDIA Corporation - Common Stock
- [INCY](https://www.lighthorse.io/tickers/incy) — Incyte Corporation - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).